Molecule Details
InChIKeyYBHILYKTIRIUTE-UHFFFAOYSA-N
Compound NameBerberine
Canonical SMILESCOc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)11
Pfam Stratification Cross-Family
Avg pChEMBL6.75
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB04115
Drug NameBerberine
CAS Number2086-83-1
Groups approved investigational withdrawn
ATC Codes nan
DescriptionAn alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.

Categories: Alkaloids Benzylisoquinolines Berberine Alkaloids Heterocyclic Compounds, Fused-Ring
Cross-references: BindingDB: 50203126 ChEBI: 16118 CHEMBL295124 ChemSpider: 2263 C00757 D00092 PDB: BER PharmGKB: PA165860812 PubChem:2353 PubChem:46506051 RxCUI: 1437 Therapeutic Targets Database: DNC000385 Wikipedia: Berberine ZINC: ZINC000003779067
Target Activities (11)
Target Gene Organism Category Pfam pChEMBL Type Source
P48775 TDO2 Homo sapiens Human PF03301 7.5 IC50 ChEMBL
Q16678 CYP1B1 Homo sapiens Human PF00067 7.0 IC50 ChEMBL;BindingDB
P14902 IDO1 Homo sapiens Human PF01231 6.6 IC50 ChEMBL
P18089 ADRA2B Homo sapiens Human PF00001 6.4 IC50 ChEMBL
P18825 ADRA2C Homo sapiens Human PF00001 6.4 Ki ChEMBL
Q99720 SIGMAR1 Homo sapiens Human PF04622 6.3 Ki ChEMBL
P22303 ACHE Homo sapiens Human PF08674 PF00135 6.2 IC50 ChEMBL;BindingDB
Q07869 PPARA Homo sapiens Human PF00104 PF00105 6.1 Ki ChEMBL
P11229 CHRM1 Homo sapiens Human PF00001 6.1 Ki ChEMBL
Q9S446 srtA Staphylococcus aureus Pathogen PF04203 8.0 IC50 BindingDB
P0A9A6 ftsZ Escherichia coli (strain K12) Pathogen PF12327 PF00091 7.6 Kd ChEMBL;BindingDB
DrugBank Target Actions (3)
Target Gene Target Name Action Type
O15392 O15392 Baculoviral IAP repeat-containing protein 5 binder targets
P0A0N5 P0A0N5 HTH-type transcriptional regulator QacR binder targets
O14746 TERT Telomerase reverse transcriptase inhibitor targets